Cargando…
Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
Nerve Growth Factor (NGF) is being considered as a therapeutic candidate for Alzheimer's disease (AD) treatment but the clinical application is hindered by its potent pro-nociceptive activity. Thus, to reduce systemic exposure that would induce pain, in recent clinical studies NGF was administe...
Autores principales: | Capsoni, Simona, Marinelli, Sara, Ceci, Marcello, Vignone, Domenico, Amato, Gianluca, Malerba, Francesca, Paoletti, Francesca, Meli, Giovanni, Viegi, Alessandro, Pavone, Flaminia, Cattaneo, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364340/ https://www.ncbi.nlm.nih.gov/pubmed/22666365 http://dx.doi.org/10.1371/journal.pone.0037555 |
Ejemplares similares
-
Correction: Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
por: Capsoni, Simona, et al.
Publicado: (2012) -
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor
por: Capsoni, Simona, et al.
Publicado: (2017) -
Taking Pain Out of NGF: A “Painless” NGF Mutant, Linked
to Hereditary Sensory Autonomic Neuropathy Type V, with Full Neurotrophic
Activity
por: Capsoni, Simona, et al.
Publicado: (2011) -
Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation
por: Capsoni, Simona, et al.
Publicado: (2013) -
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome
por: Capsoni, Simona, et al.
Publicado: (2022)